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Summary: The distribution of gonadotropin receptor and adenylate cyclase 
activities has been monitored in Sepharose 6B chromatographic eluates of a 
Lubrol solubilized fraction of 25 day old rat ovarian tissue. The receptor 
was resolved from the adenylate cyclase activity. Chromatography of a 
gonadotropin desensitized rat ovarian preparation showed that the desensi- 
tized preparation contained normal amounts of the adenylate cyclase activity 
when compared with the control ovarian preparation, but there was a marked 
reduction in the receptor activity in the desensitized ovaries. This study 
demonstrates that in ovarian tissue adenylate cyclase is a separate entity 
distinct from the receptor molecule and that the desensitization causes a 
reduction in the receptor activity with no detectable change in the catalytic 
and chromatographic properties of the adenylate cyclase. 
INTRODUCTION 
Down regulation of ovarian LH receptors has been reported following a 
single injection of hCG (1, 2). Kinetic analysis of the binding reaction 
revealed that the loss of receptor following hormone injection is due to a 
decrease in the receptor number rather than a change in the affinity of the 
receptor. Since the loss of receptor activity is accompanied by a loss of 
hormone induced cyclic AMP accumulation, we have attempted to examine the 
properties of the receptor and adenylate cyclase following solubilization and 
chromatography on gel filtration columns. Our results suggest that i) the 
hCG receptor and adenylate cyclase exist as physically separable entities in 
the rat ovary and ii) pretreatment of rats with hCG results in the loss of 
ovarian hCG receptor with no change in the adenylate cyclase component with 
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respect to its elution properties from Sepharose 66 columns as well as its 
stimulation by fluoride and magnesium ion. 
MATERIALS AND METHODS 
Materials 
[a-s2P] Adenosine triphosphate was purchased from ICN Chemical and 
Radioisotope Division, Irvine, California. Cyclic [3H] adenosine 3',5'- 
monophosphate was purchased from Amersham-Searle. [lL51] hCG was prepared by 
the procedure of Catt et al. (3). Unlabeled hCG used in these studies was -- 
generously donated by Dr. Robert E. Canfield, Columbia University and the 
Center for Population Research, NICHD. All other chemicals used were conven- 
tional commercial products. 
Assay of adenylate cyclase: The procedure of Salomon et al. (4) was used for 
the assay of adenylate cyclase. This involved incubationof samples with 
[a-12P] ATP followed by chromatographic separation of L3'P] CAMP from other 
metabolites of ATP on Dowex and Alumina columns. The recovery of CAMP on the 
columns was monitored by the addition of rsH] CAMP after the incubation step 
and by determining the amount of [3H] CAMP recovered in the column effluents. 
Assay of hCG receptor activity: The receptor activity was assayed in the 
soluble fraction and the column effluents by the procedure described pre- 
viously from our laboratory (5). Seventy microliters of the column effluent 
were incubated with 80,000 cpm [ lz51] hCG in the presence of 230 ~1 buffer 
containing 25 mM Tris HCl, pH 7.5, 1 mM CaCl, and 0.1% BSA in a final volume 
of 300 ul. After incubation at 37C for 30 min, 200 ~1 of 0.1 M sodium phos- 
phate buffer, pH 7.5, 0.5 ml of 0.2% y-globulin in 0.1 M sodium phosphate, 
pH 7.5, and 0.1 ml of 25% polyethylene glycol were added, and the contents 
were mixed well. The resultant precipitate was centrifuged at 6,000 rpm for 
10 min in a Sorvall centrifuge fitted with an SS34 rotor. The supernatant 
was decanted and the sediment was resuspended in 0.5 ml of 25 mM Tris HCl, 
pH 7.4, and to this 0.5 ml of 0.1 M sodium phosphate, pH 7.4, and 1.0 ml of 
25% polyethylene glycol in phosphate buffer were added. The mixture was 
vortexed well and the precipitate was centrifuged as in the first step. The 
supernatant was discarded, and the residue was suspended in 0.5 ml phosphate 
buffer and radioactivity determined in a gamma counter. A parallel incuba- 
tion was carried out under similar conditions with the exception that lOOO- 
fold excess unlabeled hCG was also included in the assay. The specific 
binding was determined by subtracting from the total radioactivity the amount 
of radioactivity associated with incubations containing lOOO-fold excess hCG. 
Solubilization of hCG-receptor and adenylate cyclase activities: Although 
conditions for the solubilization of either hCG-receptor alone (5) or adeny- 
late cyclase (6, 7) have been described in the ovarian tissue, the present 
experimental design necessitated simultaneous assay of hCG receptor and 
adenylate cyclase activities in column effluents. Thus, ideal conditions 
were sought in which both activities could be solubilized and recovered with 
satisfactory yield. Although 1% Triton X-100 caused 74% solubilization of the 
receptor activity with 30% recovery of the receptor at the end of the centrif- 
ugation step, this procedure caused marked inhibition of the adenylate cyclase 
activity. Sonication also caused complete destruction of adenylate cyclase 
activity. Approximately 50% of both activities were solubilized when the 
ovarian tissue was homogenized in a medium containing 50 mM Tris HCl, pH 7.4, 
1 mM EDTA, 5 mM MgCl,, 5 mM KF, 0.25 M sucrose and 2% Lubrol PX The solu- 
bilization procedure was carried out as follows: Fresh ovarian tissue or 
frozen bovine corpus luteum was weighed, cut into small pieces and homoge- 
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nized for 1 minute in 2 vols of the homogenizing buffer of the composition 
described above in a glass homogenizer with a loose fitting teflon pestle. 
During homogenization, care was taken to avoid heating by immersing the 
homogenizer in an ice slush throughout the procedure. After procedure, the 
homogenate was kept in ice for 1 h. This was followed by centrifugation at 
6500xg for 15 min and the resulting supernatant was further centrifuged at 
150,OOOxg for 1 h. The resulting supernatant is the soluble fraction. 
Sepharose column chromatography: Under our experimental conditions, [lL511 
hCG binding activity was found to be very labile on storage after solubiliza- 
tion and chromatography. For this reason, we used small columns (24 x 0.9 cm 
internal diameter) and both the activities were assayed in the column 
effluents on the same day as chromatography. The soluble fraction (0.7 ml) 
was applied to the column which has been previously equilibrated with the 
homogenizing buffer containing 0.2% Lubro?. The column was eluted with a 
medium containing 50 mM Tris HCl, pH 7.4, 1 mM EDTA, 5 mM MgClz, 5 mM KF, 
0.25 M sucrose and 0.2% Lubrol PX at a flow rate of 4 ml/h. One ml fractions 
were collected. 
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Fig. 1 Effect of increasing Lubrol concentrations on solubilization of 
adenylate cyclase from rat ovary. 
Ovaries collected from 26 day old rats were pooled. Each pool 
contained the tissues from 10 rats. The pooled tissue was homo- 
genized for 1 min in 2 volumes of buffer containing 50 mM Tris HCl, 
pH 7.4, 1 mM EDTA, 5 mM MgC12, 5 mM KF, 0.25 M sucrose and 0, 0.2, 
0.5. 1.0. 2.0 or 3.0% Lubrol PX. Further details concerning the 
hokgeniiation procedure are described in the text. The homogenate 
was allowed to remain at 4 C for 1 hr and then centrifuged at 
6500xg for 15 min. The supernatant was further centrifuged at 
150,OOOxg for 1 hr. The resulting supernatant is the soluble enzyme. 
Twenty-five microliters of this preparation was then tested for 
adenylate cyclase activity. The results are the means of three 
deteminations. 
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RESULTS 
The effect of increasing concentrations of Lubrol PX on solubilization of 
adenylate cyclase: The yield of adenylate cyclase in the 105,OOOxg super- - 
natant fraction increased with increasing concentrations of Lubrol PX up to 
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Fig. 2 Effect of hCG injection on pz51] hCG binding and adenylate cyclase 
activities. Panel A, control; Panel B, hCG injected group. 
Ten rats (26 day old) were injected with 25 IU of hCG in 0.2 ml 
subcutaneously. A control group of 10 rats was injected with an 
equal volume of saline. Twenty-four hrs later both groups were 
sacrificed, ovaries removed and the tissue from the respective 
groups pooled and weighed. The ovaries were then solubilized and the 
soluble fractions applied to Sepharose 6B columns (24 cm x 0.9 cm 
I.D.) which had been equilibrated with the same buffer containing 
0.2% Lubrol PX. The column was run at a flow rate of 4 ml/hr and 
1.0 ml fractions were collected. An aliquot (70 ~1) of each fraction 
was assayed for [125I] hCG binding (----) and adenylate cyclase 
activity (-). 
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experiments. Although the receptor activity was also solubilized with 
Triton X-100, this treatment completely destroyed adenylate cyclase activity. 
Thus, Lubrol PX was the detergent of choice for solubilization of both the 
activities. 
Effect of in vivo treatment with hCG on [ 125] hCG binding and adenylate cyclase 
activities in the column effluents: 25 day old rats were treated with 25 IU 
hCG subcutaneously, and 24 hrs later they were sacrificed by cervical dis- 
location and the ovaries removed. A control group was treated with an equal 
volume of saline. The ovaries of both groups were separately homogenized in 
two volumes of the homogenizing buffer, and the soluble fraction was prepared 
as described under "Materials and Methods." 
Figure 2 depicts the chromatographic profile of the hormone treated 
(Panel 6) and control (Panel A) ovaries when assayed for [lz51] hCG binding 
and adenylate cyclase activities. As can be seen, both activities were 
resolved from one another on the column under the experimental conditions. 
In addition, as expected, there was a marked decrease in [1251] hCG receptor 
activity in the experiments employing ovaries prepared from animals treated 
with hCG compared to the group of animals not treated with hCG. By contrast, 
pretreatment with hCG produced no change either in the position of elution of 
adenylate cyclase or in the total yield of enzyme activity. 
Fluoride and Mg2+ dependency of adenylate cyclase: The adenylate cyclase in 
the column effluents was then tested with respect to its stimulation by 
fluoride and Mg2* ions. 
The effect of increasing fluoride concentration on adenylate cyclase is 
shown in Fig. 3. In ovaries from both hormone injected and control groups, 
the concentration of fluoride ion required for maximal activity was 30 mM. 
In both instances, the enzyme activity declined with a further increase in 
fluoride concentration. The fluoride dependency for adenylate cyclase in both 
the control and hormone injected groups were identical. 
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Fig. 3 Effect of increasing concentrations of fluoride ion on adenylate 
cyclase activity in Sepharose 68 column effluents of soluble rat 
ovarian preparations. 
Sepharose 6B fractions containing the peak of adenylate cyclase 
activity were pooled and assayed in the presence of varying concen- 
trations of fluoride. 
The effect of increasing concentrations of Mg'+ on adenylate cyclase 
activity was the same in the control and hormone injected groups (Fig. 4). 
In both cases, the concentration of Mg i+ for optimal activity was 5 mM, and 
at higher concentrations it caused a slight inhibition. 
DISCUSSION 
Although there is considerable reference to the fact that the binding of 
gonadotropins to the ovarian receptors and subsequent activation of adenylate 
cyclase are early events in hormone action in the ovary, knowledge of the 
physical association between receptor and adenylate cyclase in ovarian tissue 
is relatively slight. In the B-adrenergic system, adenylate cyclase has been 
shown to be separable from B-adrenergic receptor (8, 9, 10, 11). Thus our 
attention was focused primarily on the simultaneous solubilization of both 
activities and their possible physical separation on gel filtration columns, 
The best success was achieved when small columns were employed which cut 
down the dilution of the two activities as well as the duration of exposure 
of the activities on the columns. Under the present experimental conditions, 
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Fig. 4 Effect of increasing concentrations of Mg2+ ion on adenylate cyclase 
activity in Sepharose 68 column effluents of ovarian preparations 
from control and hCG injected animals. 
The experimental conditions are similar to that described for Fig. 3 
with the exception that adenylate cyclase assay was carried out with 
different concentrations of Mgzt ion. Each assay was carried out in 
triplicate. 
the adenylate cyclase activity can be stored up to 1 week at -2O"C, whereas 
the receptor suffered rapid loss of activity upon storage. 
The chromatographic profile of the solubilized ovarian extract on 
Sepharose 6B columns revealed that the receptor was separable from the 
fluoride stimulated adenylate cyclase. However, two important factors seemed 
to influence the separation of the receptor from the cyclase on Sepharose 
columns. First, it was absolutely necessary to include Lubrol in the elution 
buffer. In the absence of Lubrol, the proteins seemed to aggregate, affect- 
ing the separation. Second, it was also critical to make certain that the 
soluble fraction was free of the light microsomal particles. Dufau et al.(lZ) 
also have reported that the adenylate cyclase is separable from the receptor 
in the luteinized rat ovary. 
We have also demonstrated that the decrease in the hCG receptor concen- 
tration observed after in vivo injection of hCG does not affect the concentra- -- 
tion or the properties of the adenylate cyclase as evidenced by a decrease in 
[l25I] hCG binding component in the hCG injected group with normal adenylate 
cyclase activity (Fig. 2). In addition, in the desensitized state, ovarian 
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adenylate cyclase was fully active in agreement with previous observations 
that, in the desensitized state, cholera toxin did stimulate the adenylate 
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